Balboa Wealth Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,445
| Closed | -$916K | – | 401 |
|
|
2025
Q1 | $916K | Sell |
1,445
-7
| -0.5% | -$4.44K | 0.22% | 83 |
|
|
2024
Q4 | $1.03M | Sell |
1,452
-47
| -3% | -$33.5K | 0.24% | 75 |
|
|
2024
Q3 | $1.58M | Sell |
1,499
-119
| -7% | -$125K | 0.39% | 42 |
|
|
2024
Q2 | $1.7M | Sell |
1,618
-674
| -29% | -$708K | 0.45% | 38 |
|
|
2024
Q1 | $2.21M | Buy |
2,292
+98
| +4% | +$94.3K | 0.65% | 25 |
|
|
2023
Q4 | $1.93M | Sell |
2,194
-304
| -12% | -$267K | 0.64% | 26 |
|
|
2023
Q3 | $2.06M | Sell |
2,498
-12
| -0.5% | -$9.88K | 0.77% | 22 |
|
|
2023
Q2 | $1.8M | Sell |
2,510
-205
| -8% | -$147K | 0.63% | 25 |
|
|
2023
Q1 | $2.23M | Buy |
2,715
+226
| +9% | +$186K | 0.84% | 21 |
|
|
2022
Q4 | $1.8M | Sell |
2,489
-115
| -4% | -$83K | 0.81% | 23 |
|
|
2022
Q3 | $1.79M | Buy |
+2,604
| New | +$1.79M | 0.79% | 21 |
|